LRIG2 promotes glioblastoma progression by modulating innate antitumor immunity through macrophage infiltration and polarization.
Hu J, Dong F, He Y, Xia X, Cheng F, Chen S, Hou X, Zhang P, Liu G, Li Y, Gao Q, Dong M, Li T, Li W, Xiao Q, Li X, Yu X, Xi G, Guo D, Wu X, Wang B.
Hu J, et al.
J Immunother Cancer. 2022 Sep;10(9):e004452. doi: 10.1136/jitc-2021-004452.
J Immunother Cancer. 2022.
PMID: 36096529
Free PMC article.
Immunotherapy has recently been an attractive and promising treatment of extracranial malignancies, however, most of clinical trials for GBM immunotherapy failed due to predominant accumulation of tumor-associated microglia/macrophages (TAMs). RESULTS: High level of LRIG2/ …
Immunotherapy has recently been an attractive and promising treatment of extracranial malignancies, however, most of clinical trials for GBM …